Exhibit 107

Calculation of Filing Fee Tables

S-1

(Form Type)

Petros Pharmaceuticals, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

	Security Type		Security Class Title	Fee Calculation or Carry Forward Rule			Amount Registered		Proposed Maximum Offering Price Per Share		Maximum Aggregate Offering Price(1)(2)				Fee Rate		Amount of Registration Fee
Fees to be Paid		Equity	Common Stock, $0.0001 par value per share		457	(o)		—		—		$	20,000,000	(3)		0.00015310	$	3,062.00
Fees to be Paid		Equity	Series A Common Warrants accompanying the Common Stock or Pre-Funded Warrants		Other	(4)		—		—				(4)		—		—
Fees to be Paid		Equity	Series B Common Warrants accompanying the Common Stock or Pre-Funded Warrants		Other	(4)		—		—				(4)		—		—
Fees to be Paid		Equity	Pre-Funded Warrants		Other	(4)		—		—				(3)(4)		—		—
Fees to be Paid		Equity	Common Stock underlying the Pre-Funded Warrants (3)		457	(o)		—		—				(3)		—		—
Fees to be Paid		Equity	Common Stock underlying the Series A Common Warrants		457	(o)		—		—		$	20,000,000		$	0.00015310	$	3,062.00
Fees to be Paid		Equity	Common Stock underlying the Series B Common Warrants		457	(o)		—		—		$	20,000,000		$	0.00015310	$	3,062.00
Fees Previously Paid		Equity	Common Stock, par value $0.0001 per share		457	(o)		—		—			—			—
Carry Forward Securities		—	—		—			—		—			—			—		—
Total Offering Amounts												$	45,000,000				$	9,186.00
Total Fees Previously Paid																	$	6,889.50
Total Fee Offset																		—
Net Fee Due																	$	2,296.50

(1) Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o) under the Securities Act of 1933, as amended (the “Securities Act”).

(2)Pursuant to Rule 416(a) under the Securities Act, there are also being registered an indeterminable number of additional securities as may be issued to prevent dilution resulting from share splits, share dividends or similar transactions.

(3)The proposed maximum aggregate offering price of the Common Stock proposed to be sold in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any Pre-Funded Warrants sold in the offering and the proposed maximum aggregate offering price of the Pre-Funded Warrants proposed to be sold in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any Common Stock sold in the offering, and, as such, the proposed maximum aggregate offering price of the Common Shares and Pre-Funded Warrants (including the Common Stock issuable upon exercise of the Pre-Funded Warrants), if any, is $20,000,000.

(4)Pursuant to Rule 457(g) of the Securities Act, no separate registration fee is required for the warrants because the warrants are being registered in the same registration statement as the Common Stock issuable upon exercise of the warrants.